← Leaderboards
Ross S Summer
Boston University Medical Campus
$6,263,506
Attributed
$7,666,151
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $774.9K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,666,151 · 6
By mechanism
R01$6,308,601 · 3
K08$641,550 · 1
R21$409,500 · 1
R41$306,500 · 1
Top collaborators
- Jianxin Sun6 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoLungInjuryMolecularGrantCellsIn VitroProteinsInvestigationAttenuatedPhosphorylationPlayDesignBiologyInterestMediatingInflammatoryEnzymesFosteringAgonistPathogenesisLaboratoriesBlood VesselsKnock-Down
Grant awards (23)
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$635,918
R01 · FY2024 · HL
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$648,894
R01 · FY2023 · HL
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$106,080
R01 · FY2023 · HL
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$648,894
R01 · FY2022 · HL
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$125,970
R01 · FY2022 · HL
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$639,534
R01 · FY2021 · HL
Metabolic control of DNA repair in pulmonary fibrosis$390,690
R01 · FY2020 · HL · contact PI
Soft LXR Agonists for Idiopathic Pulmonary Fibrosis$306,500
R41 · FY2020 · HL · contact PI
Metabolic control of DNA repair in pulmonary fibrosis$390,676
R01 · FY2019 · HL · contact PI
Metabolic control of DNA repair in pulmonary fibrosis$392,902
R01 · FY2018 · HL · contact PI
Metabolic control of DNA repair in pulmonary fibrosis$402,414
R01 · FY2017 · HL · contact PI
Alcohol-induced lung lipid changes contribute to development of acute lung injury$185,250
R21 · FY2016 · AA · contact PI
Adiponectin inhibits activation and injury of lung endothelium$381,687
R01 · FY2015 · HL · contact PI
Alcohol-induced lung lipid changes contribute to development of acute lung injury$224,250
R21 · FY2015 · AA · contact PI
Adiponectin inhibits activation and injury of lung endothelium$379,750
R01 · FY2014 · HL · contact PI
Adiponectin inhibits activation and injury of lung endothelium$368,900
R01 · FY2013 · HL · contact PI
Adiponectin inhibits activation and injury of lung endothelium$387,500
R01 · FY2012 · HL · contact PI
Adiponectin inhibits activation and injury of lung endothelium$408,792
R01 · FY2011 · HL · contact PI
The Identification and Study of a Lung Mesenchymal Stem Cell$128,310
K08 · FY2010 · HL · contact PI
The Identification and Study of a Lung Mesenchymal Stem Cell$128,310
K08 · FY2009 · HL · contact PI
The Identification and Study of a Lung Mesenchymal Stem Cell$128,310
K08 · FY2008 · HL · contact PI
The Identification and Study of a Lung Mesenchymal Stem Cell$128,310
K08 · FY2007 · HL · contact PI
The Identification and Study- Lung Mesenchymal Stem Cell$128,310
K08 · FY2006 · HL · contact PI